1h Free Analyst Time
The global gastritis market is forecasted to grow by USD 1.50 billion during 2024-2029, accelerating at a CAGR of 4.6% during the forecast period. The report on the global gastritis market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by pervasive helicobacter pylori infection and detrimental lifestyle factors, technological and therapeutic advancements, expanding geriatric population and growing health awareness.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global gastritis market is segmented as below:
By Route Of Administration
- Oral
- Parenteral
By End-User
- Hospitals and clinics
- Specialty centers
- Homecare settings
By Type
- Acute gastritis
- Chronic gastritis
- Erosive gastritis
- Non-erosive gastritis
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Russia
- Asia
- Rest of World (RoW)
The report on the global gastritis market covers the following areas:
- Global gastritis market sizing
- Global gastritis market forecast
- Global gastritis market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2024-2029
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Gastritis Market 2019 - 2023
- Historic Market Size - Data Table on Global Gastritis Market 2019 - 2023 ($ million)
- Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
- Historic Market Size - Type Segment 2019 - 2023 ($ million)
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 The AI impact on global gastritis market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- Threat of new entrants - Impact of key factors in 2024 and 2029
- Threat of substitutes - Impact of key factors in 2024 and 2029
- Threat of rivalry - Impact of key factors in 2024 and 2029
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Route of Administration
8.1 Market segments
- Chart on Route of Administration - Market share 2024-2029 (%)
- Data Table on Route of Administration - Market share 2024-2029 (%)
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- Chart on Oral - Market size and forecast 2024-2029 ($ million)
- Data Table on Oral - Market size and forecast 2024-2029 ($ million)
- Chart on Oral - Year-over-year growth 2024-2029 (%)
- Data Table on Oral - Year-over-year growth 2024-2029 (%)
- Chart on Parenteral - Market size and forecast 2024-2029 ($ million)
- Data Table on Parenteral - Market size and forecast 2024-2029 ($ million)
- Chart on Parenteral - Year-over-year growth 2024-2029 (%)
- Data Table on Parenteral - Year-over-year growth 2024-2029 (%)
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
9 Market Segmentation by End-user
9.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- Chart on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
- Chart on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
- Chart on Specialty centers - Market size and forecast 2024-2029 ($ million)
- Data Table on Specialty centers - Market size and forecast 2024-2029 ($ million)
- Chart on Specialty centers - Year-over-year growth 2024-2029 (%)
- Data Table on Specialty centers - Year-over-year growth 2024-2029 (%)
- Chart on Homecare settings - Market size and forecast 2024-2029 ($ million)
- Data Table on Homecare settings - Market size and forecast 2024-2029 ($ million)
- Chart on Homecare settings - Year-over-year growth 2024-2029 (%)
- Data Table on Homecare settings - Year-over-year growth 2024-2029 (%)
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
10 Market Segmentation by Type
10.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
- Chart on Comparison by Type
- Data Table on Comparison by Type
- Chart on Acute gastritis - Market size and forecast 2024-2029 ($ million)
- Data Table on Acute gastritis - Market size and forecast 2024-2029 ($ million)
- Chart on Acute gastritis - Year-over-year growth 2024-2029 (%)
- Data Table on Acute gastritis - Year-over-year growth 2024-2029 (%)
- Chart on Chronic gastritis - Market size and forecast 2024-2029 ($ million)
- Data Table on Chronic gastritis - Market size and forecast 2024-2029 ($ million)
- Chart on Chronic gastritis - Year-over-year growth 2024-2029 (%)
- Data Table on Chronic gastritis - Year-over-year growth 2024-2029 (%)
- Chart on Erosive gastritis - Market size and forecast 2024-2029 ($ million)
- Data Table on Erosive gastritis - Market size and forecast 2024-2029 ($ million)
- Chart on Erosive gastritis - Year-over-year growth 2024-2029 (%)
- Data Table on Erosive gastritis - Year-over-year growth 2024-2029 (%)
- Chart on Non-erosive gastritis - Market size and forecast 2024-2029 ($ million)
- Data Table on Non-erosive gastritis - Market size and forecast 2024-2029 ($ million)
- Chart on Non-erosive gastritis - Year-over-year growth 2024-2029 (%)
- Data Table on Non-erosive gastritis - Year-over-year growth 2024-2029 (%)
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- Chart on Mexico - Market size and forecast 2024-2029 ($ million)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- Chart on Spain - Market size and forecast 2024-2029 ($ million)
- Data Table on Spain - Market size and forecast 2024-2029 ($ million)
- Chart on Spain - Year-over-year growth 2024-2029 (%)
- Data Table on Spain - Year-over-year growth 2024-2029 (%)
- Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
- Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
- Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
- Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
- Chart on Russia - Market size and forecast 2024-2029 ($ million)
- Data Table on Russia - Market size and forecast 2024-2029 ($ million)
- Chart on Russia - Year-over-year growth 2024-2029 (%)
- Data Table on Russia - Year-over-year growth 2024-2029 (%)
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- Chart on Indonesia - Market size and forecast 2024-2029 ($ million)
- Data Table on Indonesia - Market size and forecast 2024-2029 ($ million)
- Chart on Indonesia - Year-over-year growth 2024-2029 (%)
- Data Table on Indonesia - Year-over-year growth 2024-2029 (%)
- Chart on Thailand - Market size and forecast 2024-2029 ($ million)
- Data Table on Thailand - Market size and forecast 2024-2029 ($ million)
- Chart on Thailand - Year-over-year growth 2024-2029 (%)
- Data Table on Thailand - Year-over-year growth 2024-2029 (%)
- Chart on Singapore - Market size and forecast 2024-2029 ($ million)
- Data Table on Singapore - Market size and forecast 2024-2029 ($ million)
- Chart on Singapore - Year-over-year growth 2024-2029 (%)
- Data Table on Singapore - Year-over-year growth 2024-2029 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Australia - Market size and forecast 2024-2029 ($ million)
- Data Table on Australia - Market size and forecast 2024-2029 ($ million)
- Chart on Australia - Year-over-year growth 2024-2029 (%)
- Data Table on Australia - Year-over-year growth 2024-2029 (%)
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- Chart on South Africa - Market size and forecast 2024-2029 ($ million)
- Data Table on South Africa - Market size and forecast 2024-2029 ($ million)
- Chart on South Africa - Year-over-year growth 2024-2029 (%)
- Data Table on South Africa - Year-over-year growth 2024-2029 (%)
- Chart on UAE - Market size and forecast 2024-2029 ($ million)
- Data Table on UAE - Market size and forecast 2024-2029 ($ million)
- Chart on UAE - Year-over-year growth 2024-2029 (%)
- Data Table on UAE - Year-over-year growth 2024-2029 (%)
- Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- Chart on Turkey - Market size and forecast 2024-2029 ($ million)
- Data Table on Turkey - Market size and forecast 2024-2029 ($ million)
- Chart on Turkey - Year-over-year growth 2024-2029 (%)
- Data Table on Turkey - Year-over-year growth 2024-2029 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Pervasive helicobacter pylori infection and detrimental lifestyle factors
- Technological and therapeutic advancements
- Expanding geriatric population and growing health awareness
- Escalating antibiotic resistance in helicobacter pylori
- Diagnostic ambiguity and overlap with functional dyspepsia
- Concerns over long-term proton pump inhibitor use and genericization
- Impact of drivers and challenges in 2024 and 2029
- Paradigm shift in h. pylori eradication therapy driven by antibiotic resistance
- Integration of artificial intelligence in endoscopic diagnostics
- Growing emphasis on advanced non-invasive diagnostic methods
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
- SWOT
- Dr Reddys Laboratories Ltd. - Overview
- Dr Reddys Laboratories Ltd. - Business segments
- Dr Reddys Laboratories Ltd. - Key news
- Dr Reddys Laboratories Ltd. - Key offerings
- Dr Reddys Laboratories Ltd. - Segment focus
- SWOT
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
- Johnson and Johnson Services - Overview
- Johnson and Johnson Services - Business segments
- Johnson and Johnson Services - Key news
- Johnson and Johnson Services - Key offerings
- Johnson and Johnson Services - Segment focus
- SWOT
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
- Medtronic Plc - Overview
- Medtronic Plc - Business segments
- Medtronic Plc - Key news
- Medtronic Plc - Key offerings
- Medtronic Plc - Segment focus
- SWOT
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- Otsuka Pharmaceutical Co Ltd. - Overview
- Otsuka Pharmaceutical Co Ltd. - Product / Service
- Otsuka Pharmaceutical Co Ltd. - Key offerings
- SWOT
- Perrigo Co. Plc - Overview
- Perrigo Co. Plc - Business segments
- Perrigo Co. Plc - Key offerings
- Perrigo Co. Plc - Segment focus
- SWOT
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
- QIAGEN N.V. - Overview
- QIAGEN N.V. - Product / Service
- QIAGEN N.V. - Key news
- QIAGEN N.V. - Key offerings
- SWOT
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 7: Executive Summary - Chart on Market Segmentation by Type
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2024 and 2029
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibit 25: Historic Market Size - Data Table on Global Gastritis Market 2019 - 2023 ($ million)
Exhibit 26: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibit 27: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibit 28: Historic Market Size - Type Segment 2019 - 2023 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2024 and 2029
Exhibit 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibit 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibit 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibit 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibit 37: Chart on Market condition - Five forces 2024 and 2029
Exhibit 38: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibit 39: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibit 40: Chart on Comparison by Route of Administration
Exhibit 41: Data Table on Comparison by Route of Administration
Exhibit 42: Chart on Oral - Market size and forecast 2024-2029 ($ million)
Exhibit 43: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Exhibit 44: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibit 45: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibit 46: Chart on Parenteral - Market size and forecast 2024-2029 ($ million)
Exhibit 47: Data Table on Parenteral - Market size and forecast 2024-2029 ($ million)
Exhibit 48: Chart on Parenteral - Year-over-year growth 2024-2029 (%)
Exhibit 49: Data Table on Parenteral - Year-over-year growth 2024-2029 (%)
Exhibit 50: Market opportunity by Route of Administration ($ million)
Exhibit 51: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 52: Chart on End-user - Market share 2024-2029 (%)
Exhibit 53: Data Table on End-user - Market share 2024-2029 (%)
Exhibit 54: Chart on Comparison by End-user
Exhibit 55: Data Table on Comparison by End-user
Exhibit 56: Chart on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
Exhibit 57: Data Table on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
Exhibit 58: Chart on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
Exhibit 59: Data Table on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
Exhibit 60: Chart on Specialty centers - Market size and forecast 2024-2029 ($ million)
Exhibit 61: Data Table on Specialty centers - Market size and forecast 2024-2029 ($ million)
Exhibit 62: Chart on Specialty centers - Year-over-year growth 2024-2029 (%)
Exhibit 63: Data Table on Specialty centers - Year-over-year growth 2024-2029 (%)
Exhibit 64: Chart on Homecare settings - Market size and forecast 2024-2029 ($ million)
Exhibit 65: Data Table on Homecare settings - Market size and forecast 2024-2029 ($ million)
Exhibit 66: Chart on Homecare settings - Year-over-year growth 2024-2029 (%)
Exhibit 67: Data Table on Homecare settings - Year-over-year growth 2024-2029 (%)
Exhibit 68: Market opportunity by End-user ($ million)
Exhibit 69: Data Table on Market opportunity by End-user ($ million)
Exhibit 70: Chart on Type - Market share 2024-2029 (%)
Exhibit 71: Data Table on Type - Market share 2024-2029 (%)
Exhibit 72: Chart on Comparison by Type
Exhibit 73: Data Table on Comparison by Type
Exhibit 74: Chart on Acute gastritis - Market size and forecast 2024-2029 ($ million)
Exhibit 75: Data Table on Acute gastritis - Market size and forecast 2024-2029 ($ million)
Exhibit 76: Chart on Acute gastritis - Year-over-year growth 2024-2029 (%)
Exhibit 77: Data Table on Acute gastritis - Year-over-year growth 2024-2029 (%)
Exhibit 78: Chart on Chronic gastritis - Market size and forecast 2024-2029 ($ million)
Exhibit 79: Data Table on Chronic gastritis - Market size and forecast 2024-2029 ($ million)
Exhibit 80: Chart on Chronic gastritis - Year-over-year growth 2024-2029 (%)
Exhibit 81: Data Table on Chronic gastritis - Year-over-year growth 2024-2029 (%)
Exhibit 82: Chart on Erosive gastritis - Market size and forecast 2024-2029 ($ million)
Exhibit 83: Data Table on Erosive gastritis - Market size and forecast 2024-2029 ($ million)
Exhibit 84: Chart on Erosive gastritis - Year-over-year growth 2024-2029 (%)
Exhibit 85: Data Table on Erosive gastritis - Year-over-year growth 2024-2029 (%)
Exhibit 86: Chart on Non-erosive gastritis - Market size and forecast 2024-2029 ($ million)
Exhibit 87: Data Table on Non-erosive gastritis - Market size and forecast 2024-2029 ($ million)
Exhibit 88: Chart on Non-erosive gastritis - Year-over-year growth 2024-2029 (%)
Exhibit 89: Data Table on Non-erosive gastritis - Year-over-year growth 2024-2029 (%)
Exhibit 90: Market opportunity by Type ($ million)
Exhibit 91: Data Table on Market opportunity by Type ($ million)
Exhibit 92: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 93: Chart on Market share by geography 2024-2029 (%)
Exhibit 94: Data Table on Market share by geography 2024-2029 (%)
Exhibit 95: Chart on Geographic comparison
Exhibit 96: Data Table on Geographic comparison
Exhibit 97: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibit 98: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibit 99: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibit 100: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibit 101: Chart on Regional Comparison - North America
Exhibit 102: Data Table on Regional Comparison - North America
Exhibit 103: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibit 104: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibit 105: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibit 106: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibit 107: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibit 108: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibit 109: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibit 110: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibit 111: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibit 112: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibit 113: Chart on Mexico - Year-over-year growth 2024-2029 (%)
Exhibit 114: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
Exhibit 115: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibit 116: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibit 117: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibit 118: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibit 119: Chart on Regional Comparison - Europe
Exhibit 120: Data Table on Regional Comparison - Europe
Exhibit 121: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibit 122: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibit 123: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibit 124: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibit 125: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibit 126: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibit 127: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibit 128: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibit 129: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibit 130: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibit 131: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibit 132: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibit 133: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibit 134: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibit 135: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibit 136: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibit 137: Chart on Spain - Market size and forecast 2024-2029 ($ million)
Exhibit 138: Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Exhibit 139: Chart on Spain - Year-over-year growth 2024-2029 (%)
Exhibit 140: Data Table on Spain - Year-over-year growth 2024-2029 (%)
Exhibit 141: Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
Exhibit 142: Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
Exhibit 143: Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
Exhibit 144: Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
Exhibit 145: Chart on Russia - Market size and forecast 2024-2029 ($ million)
Exhibit 146: Data Table on Russia - Market size and forecast 2024-2029 ($ million)
Exhibit 147: Chart on Russia - Year-over-year growth 2024-2029 (%)
Exhibit 148: Data Table on Russia - Year-over-year growth 2024-2029 (%)
Exhibit 149: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibit 150: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibit 151: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibit 152: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibit 153: Chart on Regional Comparison - Asia
Exhibit 154: Data Table on Regional Comparison - Asia
Exhibit 155: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibit 156: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibit 157: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibit 158: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibit 159: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibit 160: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibit 161: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibit 162: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibit 163: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibit 164: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibit 165: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibit 166: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibit 167: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibit 168: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibit 169: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibit 170: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibit 171: Chart on Indonesia - Market size and forecast 2024-2029 ($ million)
Exhibit 172: Data Table on Indonesia - Market size and forecast 2024-2029 ($ million)
Exhibit 173: Chart on Indonesia - Year-over-year growth 2024-2029 (%)
Exhibit 174: Data Table on Indonesia - Year-over-year growth 2024-2029 (%)
Exhibit 175: Chart on Thailand - Market size and forecast 2024-2029 ($ million)
Exhibit 176: Data Table on Thailand - Market size and forecast 2024-2029 ($ million)
Exhibit 177: Chart on Thailand - Year-over-year growth 2024-2029 (%)
Exhibit 178: Data Table on Thailand - Year-over-year growth 2024-2029 (%)
Exhibit 179: Chart on Singapore - Market size and forecast 2024-2029 ($ million)
Exhibit 180: Data Table on Singapore - Market size and forecast 2024-2029 ($ million)
Exhibit 181: Chart on Singapore - Year-over-year growth 2024-2029 (%)
Exhibit 182: Data Table on Singapore - Year-over-year growth 2024-2029 (%)
Exhibit 183: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibit 184: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibit 185: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibit 186: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibit 187: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 188: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 189: Chart on Australia - Market size and forecast 2024-2029 ($ million)
Exhibit 190: Data Table on Australia - Market size and forecast 2024-2029 ($ million)
Exhibit 191: Chart on Australia - Year-over-year growth 2024-2029 (%)
Exhibit 192: Data Table on Australia - Year-over-year growth 2024-2029 (%)
Exhibit 193: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibit 194: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibit 195: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibit 196: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibit 197: Chart on South Africa - Market size and forecast 2024-2029 ($ million)
Exhibit 198: Data Table on South Africa - Market size and forecast 2024-2029 ($ million)
Exhibit 199: Chart on South Africa - Year-over-year growth 2024-2029 (%)
Exhibit 200: Data Table on South Africa - Year-over-year growth 2024-2029 (%)
Exhibit 201: Chart on UAE - Market size and forecast 2024-2029 ($ million)
Exhibit 202: Data Table on UAE - Market size and forecast 2024-2029 ($ million)
Exhibit 203: Chart on UAE - Year-over-year growth 2024-2029 (%)
Exhibit 204: Data Table on UAE - Year-over-year growth 2024-2029 (%)
Exhibit 205: Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
Exhibit 206: Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
Exhibit 207: Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
Exhibit 208: Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
Exhibit 209: Chart on Turkey - Market size and forecast 2024-2029 ($ million)
Exhibit 210: Data Table on Turkey - Market size and forecast 2024-2029 ($ million)
Exhibit 211: Chart on Turkey - Year-over-year growth 2024-2029 (%)
Exhibit 212: Data Table on Turkey - Year-over-year growth 2024-2029 (%)
Exhibit 213: Market opportunity by geography ($ million)
Exhibit 214: Data Tables on Market opportunity by geography ($ million)
Exhibit 215: Impact of drivers and challenges in 2024 and 2029
Exhibit 216: Overview on criticality of inputs and factors of differentiation
Exhibit 217: Overview on factors of disruption
Exhibit 218: Impact of key risks on business
Exhibit 219: Companies covered
Exhibit 220: Company ranking index
Exhibit 221: Matrix on companies position and classification
Exhibit 222: Abbott Laboratories - Overview
Exhibit 223: Abbott Laboratories - Business segments
Exhibit 224: Abbott Laboratories - Key news
Exhibit 225: Abbott Laboratories - Key offerings
Exhibit 226: Abbott Laboratories - Segment focus
Exhibit 227: SWOT
Exhibit 228: AbbVie Inc. - Overview
Exhibit 229: AbbVie Inc. - Product / Service
Exhibit 230: AbbVie Inc. - Key news
Exhibit 231: AbbVie Inc. - Key offerings
Exhibit 232: SWOT
Exhibit 233: AstraZeneca Plc - Overview
Exhibit 234: AstraZeneca Plc - Product / Service
Exhibit 235: AstraZeneca Plc - Key news
Exhibit 236: AstraZeneca Plc - Key offerings
Exhibit 237: SWOT
Exhibit 238: Cipla Inc. - Overview
Exhibit 239: Cipla Inc. - Business segments
Exhibit 240: Cipla Inc. - Key news
Exhibit 241: Cipla Inc. - Key offerings
Exhibit 242: Cipla Inc. - Segment focus
Exhibit 243: SWOT
Exhibit 244: Dr Reddys Laboratories Ltd. - Overview
Exhibit 245: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 246: Dr Reddys Laboratories Ltd. - Key news
Exhibit 247: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 248: Dr Reddys Laboratories Ltd. - Segment focus
Exhibit 249: SWOT
Exhibit 250: GlaxoSmithKline Plc - Overview
Exhibit 251: GlaxoSmithKline Plc - Business segments
Exhibit 252: GlaxoSmithKline Plc - Key news
Exhibit 253: GlaxoSmithKline Plc - Key offerings
Exhibit 254: GlaxoSmithKline Plc - Segment focus
Exhibit 255: SWOT
Exhibit 256: Johnson and Johnson Services - Overview
Exhibit 257: Johnson and Johnson Services - Business segments
Exhibit 258: Johnson and Johnson Services - Key news
Exhibit 259: Johnson and Johnson Services - Key offerings
Exhibit 260: Johnson and Johnson Services - Segment focus
Exhibit 261: SWOT
Exhibit 262: Lupin Ltd. - Overview
Exhibit 263: Lupin Ltd. - Business segments
Exhibit 264: Lupin Ltd. - Key news
Exhibit 265: Lupin Ltd. - Key offerings
Exhibit 266: Lupin Ltd. - Segment focus
Exhibit 267: SWOT
Exhibit 268: Medtronic Plc - Overview
Exhibit 269: Medtronic Plc - Business segments
Exhibit 270: Medtronic Plc - Key news
Exhibit 271: Medtronic Plc - Key offerings
Exhibit 272: Medtronic Plc - Segment focus
Exhibit 273: SWOT
Exhibit 274: Novartis AG - Overview
Exhibit 275: Novartis AG - Business segments
Exhibit 276: Novartis AG - Key news
Exhibit 277: Novartis AG - Key offerings
Exhibit 278: Novartis AG - Segment focus
Exhibit 279: SWOT
Exhibit 280: Otsuka Pharmaceutical Co Ltd. - Overview
Exhibit 281: Otsuka Pharmaceutical Co Ltd. - Product / Service
Exhibit 282: Otsuka Pharmaceutical Co Ltd. - Key offerings
Exhibit 283: SWOT
Exhibit 284: Perrigo Co. Plc - Overview
Exhibit 285: Perrigo Co. Plc - Business segments
Exhibit 286: Perrigo Co. Plc - Key offerings
Exhibit 287: Perrigo Co. Plc - Segment focus
Exhibit 288: SWOT
Exhibit 289: Pfizer Inc. - Overview
Exhibit 290: Pfizer Inc. - Product / Service
Exhibit 291: Pfizer Inc. - Key news
Exhibit 292: Pfizer Inc. - Key offerings
Exhibit 293: SWOT
Exhibit 294: QIAGEN N.V. - Overview
Exhibit 295: QIAGEN N.V. - Product / Service
Exhibit 296: QIAGEN N.V. - Key news
Exhibit 297: QIAGEN N.V. - Key offerings
Exhibit 298: SWOT
Exhibit 299: Sanofi SA - Overview
Exhibit 300: Sanofi SA - Business segments
Exhibit 301: Sanofi SA - Key news
Exhibit 302: Sanofi SA - Key offerings
Exhibit 303: Sanofi SA - Segment focus
Exhibit 304: SWOT
Exhibit 305: Inclusions checklist
Exhibit 306: Exclusions checklist
Exhibit 307: Currency conversion rates for US$
Exhibit 308: Research methodology
Exhibit 309: Information sources
Exhibit 310: Data validation
Exhibit 311: Validation techniques employed for market sizing
Exhibit 312: Data synthesis
Exhibit 313: 360 degree market analysis
Exhibit 314: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 7: Executive Summary - Chart on Market Segmentation by Type
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2024 and 2029
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibit 25: Historic Market Size - Data Table on Global Gastritis Market 2019 - 2023 ($ million)
Exhibit 26: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibit 27: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibit 28: Historic Market Size - Type Segment 2019 - 2023 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2024 and 2029
Exhibit 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibit 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibit 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibit 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibit 37: Chart on Market condition - Five forces 2024 and 2029
Exhibit 38: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibit 39: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibit 40: Chart on Comparison by Route of Administration
Exhibit 41: Data Table on Comparison by Route of Administration
Exhibit 42: Chart on Oral - Market size and forecast 2024-2029 ($ million)
Exhibit 43: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Exhibit 44: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibit 45: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibit 46: Chart on Parenteral - Market size and forecast 2024-2029 ($ million)
Exhibit 47: Data Table on Parenteral - Market size and forecast 2024-2029 ($ million)
Exhibit 48: Chart on Parenteral - Year-over-year growth 2024-2029 (%)
Exhibit 49: Data Table on Parenteral - Year-over-year growth 2024-2029 (%)
Exhibit 50: Market opportunity by Route of Administration ($ million)
Exhibit 51: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 52: Chart on End-user - Market share 2024-2029 (%)
Exhibit 53: Data Table on End-user - Market share 2024-2029 (%)
Exhibit 54: Chart on Comparison by End-user
Exhibit 55: Data Table on Comparison by End-user
Exhibit 56: Chart on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
Exhibit 57: Data Table on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
Exhibit 58: Chart on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
Exhibit 59: Data Table on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
Exhibit 60: Chart on Specialty centers - Market size and forecast 2024-2029 ($ million)
Exhibit 61: Data Table on Specialty centers - Market size and forecast 2024-2029 ($ million)
Exhibit 62: Chart on Specialty centers - Year-over-year growth 2024-2029 (%)
Exhibit 63: Data Table on Specialty centers - Year-over-year growth 2024-2029 (%)
Exhibit 64: Chart on Homecare settings - Market size and forecast 2024-2029 ($ million)
Exhibit 65: Data Table on Homecare settings - Market size and forecast 2024-2029 ($ million)
Exhibit 66: Chart on Homecare settings - Year-over-year growth 2024-2029 (%)
Exhibit 67: Data Table on Homecare settings - Year-over-year growth 2024-2029 (%)
Exhibit 68: Market opportunity by End-user ($ million)
Exhibit 69: Data Table on Market opportunity by End-user ($ million)
Exhibit 70: Chart on Type - Market share 2024-2029 (%)
Exhibit 71: Data Table on Type - Market share 2024-2029 (%)
Exhibit 72: Chart on Comparison by Type
Exhibit 73: Data Table on Comparison by Type
Exhibit 74: Chart on Acute gastritis - Market size and forecast 2024-2029 ($ million)
Exhibit 75: Data Table on Acute gastritis - Market size and forecast 2024-2029 ($ million)
Exhibit 76: Chart on Acute gastritis - Year-over-year growth 2024-2029 (%)
Exhibit 77: Data Table on Acute gastritis - Year-over-year growth 2024-2029 (%)
Exhibit 78: Chart on Chronic gastritis - Market size and forecast 2024-2029 ($ million)
Exhibit 79: Data Table on Chronic gastritis - Market size and forecast 2024-2029 ($ million)
Exhibit 80: Chart on Chronic gastritis - Year-over-year growth 2024-2029 (%)
Exhibit 81: Data Table on Chronic gastritis - Year-over-year growth 2024-2029 (%)
Exhibit 82: Chart on Erosive gastritis - Market size and forecast 2024-2029 ($ million)
Exhibit 83: Data Table on Erosive gastritis - Market size and forecast 2024-2029 ($ million)
Exhibit 84: Chart on Erosive gastritis - Year-over-year growth 2024-2029 (%)
Exhibit 85: Data Table on Erosive gastritis - Year-over-year growth 2024-2029 (%)
Exhibit 86: Chart on Non-erosive gastritis - Market size and forecast 2024-2029 ($ million)
Exhibit 87: Data Table on Non-erosive gastritis - Market size and forecast 2024-2029 ($ million)
Exhibit 88: Chart on Non-erosive gastritis - Year-over-year growth 2024-2029 (%)
Exhibit 89: Data Table on Non-erosive gastritis - Year-over-year growth 2024-2029 (%)
Exhibit 90: Market opportunity by Type ($ million)
Exhibit 91: Data Table on Market opportunity by Type ($ million)
Exhibit 92: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 93: Chart on Market share by geography 2024-2029 (%)
Exhibit 94: Data Table on Market share by geography 2024-2029 (%)
Exhibit 95: Chart on Geographic comparison
Exhibit 96: Data Table on Geographic comparison
Exhibit 97: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibit 98: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibit 99: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibit 100: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibit 101: Chart on Regional Comparison - North America
Exhibit 102: Data Table on Regional Comparison - North America
Exhibit 103: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibit 104: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibit 105: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibit 106: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibit 107: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibit 108: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibit 109: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibit 110: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibit 111: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibit 112: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibit 113: Chart on Mexico - Year-over-year growth 2024-2029 (%)
Exhibit 114: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
Exhibit 115: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibit 116: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibit 117: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibit 118: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibit 119: Chart on Regional Comparison - Europe
Exhibit 120: Data Table on Regional Comparison - Europe
Exhibit 121: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibit 122: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibit 123: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibit 124: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibit 125: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibit 126: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibit 127: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibit 128: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibit 129: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibit 130: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibit 131: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibit 132: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibit 133: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibit 134: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibit 135: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibit 136: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibit 137: Chart on Spain - Market size and forecast 2024-2029 ($ million)
Exhibit 138: Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Exhibit 139: Chart on Spain - Year-over-year growth 2024-2029 (%)
Exhibit 140: Data Table on Spain - Year-over-year growth 2024-2029 (%)
Exhibit 141: Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
Exhibit 142: Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
Exhibit 143: Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
Exhibit 144: Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
Exhibit 145: Chart on Russia - Market size and forecast 2024-2029 ($ million)
Exhibit 146: Data Table on Russia - Market size and forecast 2024-2029 ($ million)
Exhibit 147: Chart on Russia - Year-over-year growth 2024-2029 (%)
Exhibit 148: Data Table on Russia - Year-over-year growth 2024-2029 (%)
Exhibit 149: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibit 150: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibit 151: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibit 152: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibit 153: Chart on Regional Comparison - Asia
Exhibit 154: Data Table on Regional Comparison - Asia
Exhibit 155: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibit 156: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibit 157: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibit 158: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibit 159: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibit 160: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibit 161: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibit 162: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibit 163: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibit 164: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibit 165: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibit 166: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibit 167: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibit 168: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibit 169: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibit 170: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibit 171: Chart on Indonesia - Market size and forecast 2024-2029 ($ million)
Exhibit 172: Data Table on Indonesia - Market size and forecast 2024-2029 ($ million)
Exhibit 173: Chart on Indonesia - Year-over-year growth 2024-2029 (%)
Exhibit 174: Data Table on Indonesia - Year-over-year growth 2024-2029 (%)
Exhibit 175: Chart on Thailand - Market size and forecast 2024-2029 ($ million)
Exhibit 176: Data Table on Thailand - Market size and forecast 2024-2029 ($ million)
Exhibit 177: Chart on Thailand - Year-over-year growth 2024-2029 (%)
Exhibit 178: Data Table on Thailand - Year-over-year growth 2024-2029 (%)
Exhibit 179: Chart on Singapore - Market size and forecast 2024-2029 ($ million)
Exhibit 180: Data Table on Singapore - Market size and forecast 2024-2029 ($ million)
Exhibit 181: Chart on Singapore - Year-over-year growth 2024-2029 (%)
Exhibit 182: Data Table on Singapore - Year-over-year growth 2024-2029 (%)
Exhibit 183: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibit 184: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibit 185: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibit 186: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibit 187: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 188: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 189: Chart on Australia - Market size and forecast 2024-2029 ($ million)
Exhibit 190: Data Table on Australia - Market size and forecast 2024-2029 ($ million)
Exhibit 191: Chart on Australia - Year-over-year growth 2024-2029 (%)
Exhibit 192: Data Table on Australia - Year-over-year growth 2024-2029 (%)
Exhibit 193: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibit 194: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibit 195: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibit 196: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibit 197: Chart on South Africa - Market size and forecast 2024-2029 ($ million)
Exhibit 198: Data Table on South Africa - Market size and forecast 2024-2029 ($ million)
Exhibit 199: Chart on South Africa - Year-over-year growth 2024-2029 (%)
Exhibit 200: Data Table on South Africa - Year-over-year growth 2024-2029 (%)
Exhibit 201: Chart on UAE - Market size and forecast 2024-2029 ($ million)
Exhibit 202: Data Table on UAE - Market size and forecast 2024-2029 ($ million)
Exhibit 203: Chart on UAE - Year-over-year growth 2024-2029 (%)
Exhibit 204: Data Table on UAE - Year-over-year growth 2024-2029 (%)
Exhibit 205: Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
Exhibit 206: Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
Exhibit 207: Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
Exhibit 208: Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
Exhibit 209: Chart on Turkey - Market size and forecast 2024-2029 ($ million)
Exhibit 210: Data Table on Turkey - Market size and forecast 2024-2029 ($ million)
Exhibit 211: Chart on Turkey - Year-over-year growth 2024-2029 (%)
Exhibit 212: Data Table on Turkey - Year-over-year growth 2024-2029 (%)
Exhibit 213: Market opportunity by geography ($ million)
Exhibit 214: Data Tables on Market opportunity by geography ($ million)
Exhibit 215: Impact of drivers and challenges in 2024 and 2029
Exhibit 216: Overview on criticality of inputs and factors of differentiation
Exhibit 217: Overview on factors of disruption
Exhibit 218: Impact of key risks on business
Exhibit 219: Companies covered
Exhibit 220: Company ranking index
Exhibit 221: Matrix on companies position and classification
Exhibit 222: Abbott Laboratories - Overview
Exhibit 223: Abbott Laboratories - Business segments
Exhibit 224: Abbott Laboratories - Key news
Exhibit 225: Abbott Laboratories - Key offerings
Exhibit 226: Abbott Laboratories - Segment focus
Exhibit 227: SWOT
Exhibit 228: AbbVie Inc. - Overview
Exhibit 229: AbbVie Inc. - Product / Service
Exhibit 230: AbbVie Inc. - Key news
Exhibit 231: AbbVie Inc. - Key offerings
Exhibit 232: SWOT
Exhibit 233: AstraZeneca Plc - Overview
Exhibit 234: AstraZeneca Plc - Product / Service
Exhibit 235: AstraZeneca Plc - Key news
Exhibit 236: AstraZeneca Plc - Key offerings
Exhibit 237: SWOT
Exhibit 238: Cipla Inc. - Overview
Exhibit 239: Cipla Inc. - Business segments
Exhibit 240: Cipla Inc. - Key news
Exhibit 241: Cipla Inc. - Key offerings
Exhibit 242: Cipla Inc. - Segment focus
Exhibit 243: SWOT
Exhibit 244: Dr Reddys Laboratories Ltd. - Overview
Exhibit 245: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 246: Dr Reddys Laboratories Ltd. - Key news
Exhibit 247: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 248: Dr Reddys Laboratories Ltd. - Segment focus
Exhibit 249: SWOT
Exhibit 250: GlaxoSmithKline Plc - Overview
Exhibit 251: GlaxoSmithKline Plc - Business segments
Exhibit 252: GlaxoSmithKline Plc - Key news
Exhibit 253: GlaxoSmithKline Plc - Key offerings
Exhibit 254: GlaxoSmithKline Plc - Segment focus
Exhibit 255: SWOT
Exhibit 256: Johnson and Johnson Services - Overview
Exhibit 257: Johnson and Johnson Services - Business segments
Exhibit 258: Johnson and Johnson Services - Key news
Exhibit 259: Johnson and Johnson Services - Key offerings
Exhibit 260: Johnson and Johnson Services - Segment focus
Exhibit 261: SWOT
Exhibit 262: Lupin Ltd. - Overview
Exhibit 263: Lupin Ltd. - Business segments
Exhibit 264: Lupin Ltd. - Key news
Exhibit 265: Lupin Ltd. - Key offerings
Exhibit 266: Lupin Ltd. - Segment focus
Exhibit 267: SWOT
Exhibit 268: Medtronic Plc - Overview
Exhibit 269: Medtronic Plc - Business segments
Exhibit 270: Medtronic Plc - Key news
Exhibit 271: Medtronic Plc - Key offerings
Exhibit 272: Medtronic Plc - Segment focus
Exhibit 273: SWOT
Exhibit 274: Novartis AG - Overview
Exhibit 275: Novartis AG - Business segments
Exhibit 276: Novartis AG - Key news
Exhibit 277: Novartis AG - Key offerings
Exhibit 278: Novartis AG - Segment focus
Exhibit 279: SWOT
Exhibit 280: Otsuka Pharmaceutical Co Ltd. - Overview
Exhibit 281: Otsuka Pharmaceutical Co Ltd. - Product / Service
Exhibit 282: Otsuka Pharmaceutical Co Ltd. - Key offerings
Exhibit 283: SWOT
Exhibit 284: Perrigo Co. Plc - Overview
Exhibit 285: Perrigo Co. Plc - Business segments
Exhibit 286: Perrigo Co. Plc - Key offerings
Exhibit 287: Perrigo Co. Plc - Segment focus
Exhibit 288: SWOT
Exhibit 289: Pfizer Inc. - Overview
Exhibit 290: Pfizer Inc. - Product / Service
Exhibit 291: Pfizer Inc. - Key news
Exhibit 292: Pfizer Inc. - Key offerings
Exhibit 293: SWOT
Exhibit 294: QIAGEN N.V. - Overview
Exhibit 295: QIAGEN N.V. - Product / Service
Exhibit 296: QIAGEN N.V. - Key news
Exhibit 297: QIAGEN N.V. - Key offerings
Exhibit 298: SWOT
Exhibit 299: Sanofi SA - Overview
Exhibit 300: Sanofi SA - Business segments
Exhibit 301: Sanofi SA - Key news
Exhibit 302: Sanofi SA - Key offerings
Exhibit 303: Sanofi SA - Segment focus
Exhibit 304: SWOT
Exhibit 305: Inclusions checklist
Exhibit 306: Exclusions checklist
Exhibit 307: Currency conversion rates for US$
Exhibit 308: Research methodology
Exhibit 309: Information sources
Exhibit 310: Data validation
Exhibit 311: Validation techniques employed for market sizing
Exhibit 312: Data synthesis
Exhibit 313: 360 degree market analysis
Exhibit 314: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global gastritis market: Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Cipla Inc., Dr Reddys Laboratories Ltd., GlaxoSmithKline Plc, Johnson and Johnson Services, Lupin Ltd., Medtronic Plc, Novartis AG, Otsuka Pharmaceutical Co Ltd., Perrigo Co. Plc, Pfizer Inc., QIAGEN N.V., Sanofi SA, Takeda Pharmaceutical Ltd., Teva Pharmaceutical Ltd., Zydus Lifesciences Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is paradigm shift in h. pylori eradication therapy driven by antibiotic resistance."
According to the report, one of the major drivers for this market is the pervasive helicobacter pylori infection and detrimental lifestyle factors.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- AbbVie Inc.
- AstraZeneca Plc
- Cipla Inc.
- Dr Reddys Laboratories Ltd.
- GlaxoSmithKline Plc
- Johnson and Johnson Services
- Lupin Ltd.
- Medtronic Plc
- Novartis AG
- Otsuka Pharmaceutical Co Ltd.
- Perrigo Co. Plc
- Pfizer Inc.
- QIAGEN N.V.
- Sanofi SA
- Takeda Pharmaceutical Ltd.
- Teva Pharmaceutical Ltd.
- Zydus Lifesciences Ltd.
